1. Home
  2. RCEL vs AIRS Comparison

RCEL vs AIRS Comparison

Compare RCEL & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • AIRS
  • Stock Information
  • Founded
  • RCEL N/A
  • AIRS 2012
  • Country
  • RCEL United States
  • AIRS United States
  • Employees
  • RCEL 260
  • AIRS N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • AIRS Medical/Nursing Services
  • Sector
  • RCEL Health Care
  • AIRS Health Care
  • Exchange
  • RCEL Nasdaq
  • AIRS Nasdaq
  • Market Cap
  • RCEL 136.7M
  • AIRS 166.3M
  • IPO Year
  • RCEL N/A
  • AIRS 2021
  • Fundamental
  • Price
  • RCEL $5.71
  • AIRS $4.93
  • Analyst Decision
  • RCEL Strong Buy
  • AIRS Hold
  • Analyst Count
  • RCEL 4
  • AIRS 3
  • Target Price
  • RCEL $16.50
  • AIRS $3.75
  • AVG Volume (30 Days)
  • RCEL 308.7K
  • AIRS 590.1K
  • Earning Date
  • RCEL 08-07-2025
  • AIRS 08-08-2025
  • Dividend Yield
  • RCEL N/A
  • AIRS N/A
  • EPS Growth
  • RCEL N/A
  • AIRS N/A
  • EPS
  • RCEL N/A
  • AIRS N/A
  • Revenue
  • RCEL $71,661,000.00
  • AIRS $172,101,000.00
  • Revenue This Year
  • RCEL $57.16
  • AIRS N/A
  • Revenue Next Year
  • RCEL $36.69
  • AIRS $4.90
  • P/E Ratio
  • RCEL N/A
  • AIRS N/A
  • Revenue Growth
  • RCEL 41.35
  • AIRS N/A
  • 52 Week Low
  • RCEL $4.71
  • AIRS $1.53
  • 52 Week High
  • RCEL $14.16
  • AIRS $9.20
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.89
  • AIRS 53.44
  • Support Level
  • RCEL $5.13
  • AIRS $4.93
  • Resistance Level
  • RCEL $5.87
  • AIRS $5.65
  • Average True Range (ATR)
  • RCEL 0.31
  • AIRS 0.38
  • MACD
  • RCEL 0.14
  • AIRS -0.06
  • Stochastic Oscillator
  • RCEL 83.19
  • AIRS 34.78

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

Share on Social Networks: